Cervical disc replacement is a real and meaningful advance — but the framing that ACDR is universally better than ACDF is overselling the data. Here's the honest read.
ACDF works. The procedure has been done for more than 50 years, the outcome data on radiculopathy and myelopathy is excellent, and most patients do well. The argument against it is mechanical: fusing two vertebrae transfers slightly more motion-related stress to the discs above and below, and over 10–20 years a subset of patients develop adjacent-segment degeneration. Some of those patients become symptomatic; a smaller subset go on to need a second surgery.
ACDR addresses that mechanical argument by preserving motion at the operated level. In well-selected single- and two-level patients, FDA IDE follow-up data through 7–10 years supports lower rates of adjacent-segment reoperation compared with ACDF. The catch is patient selection. ACDR demands healthy facet joints, preserved cervical alignment, decent bone density, and the right kind of disc pathology. Drop any of those requirements and the math changes.
For multi-level disease, kyphosis, instability, osteoporosis, OPLL, or severe facet arthritis, ACDF remains the right operation, and trying to make ACDR fit those cases creates new problems. The decision is not "ACDR if it's available, ACDF if it isn't" — the decision is which physics fit your anatomy.
That's the conversation we have with every spine patient at LAOSS — not which device is newest, but which approach the imaging and exam are actually telling us to do.